Public Meeting on Patient-Generated Health Data - May 4, 2021

Register to attend by Monday, May 3, 2021.

If your email program has trouble displaying this email, view as a webpage. Virtual Public Meeting: Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices The U.S. Food and Drug Administration (FDA) is announcing a virtual public meeting, Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices. The purpose of this public meeting is to discuss patient-generated health data (PGHD) and its potential impact across the health care system. PGHD includes health-related data that is created, recorded, or gathered by or from patients, such as health and treatment history, biometric data, symptoms, and lifestyle habits. Topics include: Sources of PGHD, data quality measures, interoperability, and potential impacts of the data in regulatory and health care settings. Meeting Date: Tuesday, May 4, 2021, 10:00 a.m. - 4:00 p.m. EDT Location: This public meeting will be webcast. Registration Deadline: Monday, May 3, 2021 by 4:00 p.m. EDT Read More Other Deadlines By May 3, 2021: Request special accommodations for the meeting. Questions? If you have questions about this virtual public meeting, contact Christina Webber Christina.Webber@fda.hhs.gov.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA